Skip to main content
Equibles

BVF INC/IL

Position in MOLN — Molecular Partners AG

CIK 1056807 San Francisco, CA
Back to MOLN Full portfolio

Position in MOLN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$5,239,856
-$134,042 QoQ
Shares Held
1,353,968
0.0% QoQ
Ownership
3.53%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#2
of 5 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in MOLN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BVF INC/IL holds $3,440,293,274 across 41 Biotechnology names. MOLN ranks #36 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 2,965,160 $555,315,164
2 KYMR
Kymera Therapeutics, Inc.
 3,872,052 $444,008,202
3 MLTX
MoonLake Immunotherapeutics
 16,001,284 $311,544,999
4 GHRS
GH Research PLC
 8,650,158 $232,516,247
5 GPCR
Structure Therapeutics Inc.
 3,366,823 $180,697,390
6 NKTR
Nektar Therapeutics
 2,391,075 $166,920,945
7 MIRM
Mirum Pharmaceuticals, Inc.
 1,056,027 $123,629,080
8 XNCR
Xencor Inc
 7,133,720 $114,852,892

All Filings in MOLN

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,239,856 1,353,968
2026-03-31 $5,373,898 1,353,968
2025-12-31 $5,901,946 1,353,968
2025-09-30 $5,023,221 1,353,968
2025-06-30 $5,172,157 1,353,968
2025-03-31 $5,253,395 1,353,968
2024-12-31 $6,428,640 1,353,968
2024-09-30 $2,254,665 443,221
2024-06-30 $3,204,487 443,221
2024-03-31 $1,861,528 443,221
2023-12-31 $1,852,663 443,221
2023-09-30 $1,834,934 443,221
2023-06-30 $2,756,834 443,221
2023-03-31 $2,676,168 443,221
2022-12-31 $2,903,097 443,221
2022-09-30 $2,965,148 443,221
2022-06-30 $3,005,038 443,221
2022-03-31 $9,108,191 443,221
2021-12-31 $8,500,978 443,221
2021-09-30 $8,216,746 419,008